Aligos Therapeutics (ALGS) EBITDA (2019 - 2026)
Aligos Therapeutics (ALGS) recorded EBITDA of -$1.59 million in Q2 2026, compared with -$18.27 million a year earlier.
Powered by 
Analysis
Aligos Therapeutics (ALGS) EBITDA (2019 - 2026) Analysis & Trends
On a TTM basis, Aligos Therapeutics' EBITDA came in at -$77.92 million as of Jun 30, 2026; for FY2025, it came in at -$87.06 million.
- Across earlier years, EBITDA came in at -$88.13 million in FY2024, -$86.53 million in FY2023, -$95.27 million in FY2022 and -$125.3 million in FY2021.
- The Q2 2026 figure is the highest quarterly EBITDA in data going back to Q3 2019.
- Per Business Quant, the preceding three quarters came in at -$26.58 million (Q1 2026), -$21.58 million (Q4 2025) and -$28.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Aligos Therapeutics | 52.83 Mn | -275.57 Mn | - | -1.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.59 Mn |
| Mar 31, 2026 | -26.58 Mn |
| Dec 31, 2025 | -21.58 Mn |
| Sep 30, 2025 | -28.16 Mn |
| Jun 30, 2025 | -18.27 Mn |
| Mar 31, 2025 | -19.04 Mn |
| Dec 31, 2024 | -20.34 Mn |
| Sep 30, 2024 | -19.83 Mn |
| Jun 30, 2024 | -26.11 Mn |
| Mar 31, 2024 | -21.75 Mn |
| Dec 31, 2023 | -25.60 Mn |
| Sep 30, 2023 | -18.77 Mn |
| Jun 30, 2023 | -18.74 Mn |
| Mar 31, 2023 | -23.42 Mn |
| Dec 31, 2022 | -22.18 Mn |
| Sep 30, 2022 | -18.45 Mn |
| Jun 30, 2022 | -19.79 Mn |
| Mar 31, 2022 | -34.86 Mn |
| Dec 31, 2021 | -37.23 Mn |
| Sep 30, 2021 | -32.27 Mn |
API Access
Aligos Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();